Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations [Phase 1]
ATV-1601, an investigational therapy, is being studied in a Phase 1 trial for patients with AKT1 E17K-mutant cancers, including breast, cerv…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer [Phase 3]
A Phase 3 trial is evaluating maintenance therapy with BGB-290 (pamiparib) versus placebo in platinum-sensitive recurrent ovarian cancer, an…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer [Phase 1]
Phase 1 clinical trial evaluating MUC1-Activated T Cells for relapsed and resistant ovarian, fallopian tube, and primary peritoneal cancers;…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected [Phase 3]
A Phase 3 trial of alpelisib plus olaparib for platinum-resistant/refractory high-grade serous ovarian cancer without germline BRCA mutation…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Perioperative Morbidity in Gyneco-oncology According to the Procedure : Coelioscopy Versus Robot-assisted Coelioscopy [NA]
Clinical trial update on perioperative morbidity in gyneco-oncology comparing coelioscopy to robot-assisted coelioscopy. The Centre Oscar La…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer [Phase 2]
Phase 2 trial evaluating the combination of apatinib and etoposide in platinum-resistant or refractory ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]
This is a clinical trial update on a Phase 1/2 study evaluating pamiparib plus surufatinib for platinum-resistant ovarian cancer and related…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65). [Phase 3]
Phase 3 trial assessing pembrolizumab with paclitaxel, with or without bevacizumab, for platinum-resistant recurrent ovarian cancer; results…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1) [Phase 2, Phase 3]
A Phase 2/Phase 3 trial (ULTIMUS-1) evaluating NP-G2-044 (Prilukae) with PLD for platinum-resistant ovarian cancer is active but not recruit…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Michigan Genetic Hereditary Testing (MiGHT) [NA]
The MiGHT hereditary genetic testing trial at the University of Michigan Rogel Cancer Center has completed, evaluating testing across multip…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Choices About Genetic Testing And Learning Your Risk With Smart Technology [NA]
A completed Rutgers-led trial evaluated choices about genetic testing and learning cancer risk using smart technology across multiple cancer…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: QLS5132 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]
This update describes a Phase 1/2 study of QLS5132 combination therapy in multiple cancers, including gastric cancer, non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer [Phase 2]
Phase 2 trial evaluating the safety and efficacy of ALX148 in combination with liposomal doxorubicin and pembrolizumab for recurrent platinu…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy [Phase 2]
Phase 2 clinical trial evaluating whether tart cherry juice can prevent paclitaxel-induced neuropathy in patients with breast or ovarian can…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: ASTRA Study: Circulating Tumor Cells in Blood of Patients With High-Grade Serous Ovarian Cancer [NA]
The ASTRA study, which investigates circulating tumor cells in the blood of patients with high-grade serous ovarian cancer, has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer [NA]
This completed clinical trial assesses esketamine for prevention of depressive symptoms after cytoreductive surgery in patients with ovarian…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. [Phase 2, Phase 3]
The DETERMINE trial's Arm 07 is studying dabrafenib plus trametinib in patients with BRAF V600 mutation-positive cancers across age groups; …
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: With Love, Grandma ("Con Cariño, Abuelita") Pilot Study [NA]
A pilot trial at the University of Miami Sylvester Comprehensive Cancer Center is recruiting for 'With Love, Grandma' (Con Cariño, Abuelita)…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: PRO1107 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
The Phase 1/2 PRO1107 trial in advanced solid tumors, including endometrial and ovarian cancers, has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Individual Approach in Gynecological Cancer Brachytherapy [NA]
This completed clinical trial investigated an individualized brachytherapy approach for gynecologic cancers, aiming to optimize radiation de…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types [Phase 1, Phase 2]
This update reports a Phase 1/2 trial of atezolizumab plus tivozanib in several immunologically cold tumor types, with the study currently s…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Functional Analysis of BRCAness [Phase 2]
Phase 2 clinical trial evaluating functional analysis of BRCAness in epithelial ovarian cancer with homologous recombination deficiency (ass…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER) [Phase 3]
Phase 3 trial evaluating cytoreductive surgery with HIPEC using mitomycin C for platinum-resistant recurrent epithelial ovarian cancer is cu…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer [NA]
A completed clinical trial evaluating delaying surgery after neoadjuvant chemotherapy in advanced ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Usefulness of Video-Based Intervention in Helping Participants Encourage Their Families to Get Tested for BRCA Gene Mutations [NA]
A completed clinical trial evaluated whether a video-based intervention helps participants persuade family members to undergo BRCA1/BRCA2 ge…